首页 | 本学科首页   官方微博 | 高级检索  
     

谷维素辅助治疗原发性高血压临床研究
引用本文:沈亚东. 谷维素辅助治疗原发性高血压临床研究[J]. 中国医药导报, 2010, 7(31): 63-64
作者姓名:沈亚东
作者单位:江苏省如皋市博爱医院内科,江苏如皋,226500
摘    要:目的:观察谷维素辅助治疗原发性轻、中度高血压的疗效。方法:将82例原发性轻、中度高血压患者随机分为两组,治疗组42例,给予谷维素片加硝苯地平缓释片;对照组40例,只给予硝苯地平缓释片;两组均治疗2个月,对收缩压、舒张压的最终下降幅度进行评定。结果:治疗组收缩压、舒张压的下降幅度更明显,与对照组比较,有显著性差异(P〈0.05),两组不良反应均较轻。结论:谷维素片加硝苯地平缓释片治疗原发性轻、中度高血压比单用硝苯地平缓释片疗效更好,谷维素片可增强高血压患者降压药的效果。

关 键 词:谷维素片  硝苯地平缓释片  原发性高血压

The clinical research of Oryzanol in the assist treatment of primary hypertension
SHEN Yadong. The clinical research of Oryzanol in the assist treatment of primary hypertension[J]. China Medical Herald, 2010, 7(31): 63-64
Authors:SHEN Yadong
Affiliation:SHEN Yadong(Department of Nephrology,Bo′ai Hospital of Rugao City,Jiangsu Province,Rugao 226500,China)
Abstract:Objective: To observe the effectiveness of Oryzanol in the assist treatment of mild and moderate primary hy-pertension.Methods: 82 cases of mild and moderate primary hypertension were randomly divided into treatment group and control group,the treatment group were treated by Oryzanol and Nifedipine Sustained Release Tablets while the control group were treated by Nifedipine Sustained Release Tablets only,general treated for 2 months,the decrease amplitude of SBP and DBP were evaluated.Results: The decrease amplitude of SBP and DBP in treatment group were more obvious,compared with the control group,there was significant difference(P〈0.05),the adverse reactions were mild in two groups.Conclusion: Oryzanol combined with Nifedipine Sustained Release Tablets in the assist treatment of primary hypertension has better effectiveness than used Nifedipine Sustained Release Tablets only,Oryzanol can enhance the effect of other an-tihypertensive drug.
Keywords:Oryzanol  Nifedipine Sustained Release Tablets  Primary hypertension
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号